09:43 EDT SilverBck Ther. trading halted, volatility trading pause
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on SPRY:
- ARS Pharma (NASDAQ:SPRY) Plummets on FDA Snub for Epinephrine Nasal Spray
- ARS Pharmaceuticals issued CRL by FDA for neffy NDA, plans to appeal
- ARS downgraded to Market Perform from Outperform at William Blair
- FDA Issues Complete Response Letter for neffy® (epinephrine nasal spray) New Drug Application with Request for Additional Study
- ARS Reports Second Quarter 2023 Financial Results and Provides Business Updates